The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01751100 |
Recruitment Status
:
Withdrawn
(We did not receive proper funding to complete this study.)
First Posted
: December 17, 2012
Last Update Posted
: May 8, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections | Behavioral: HIV Test Offer Behavioral: General Health Screen Offer | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Care Provider) |
Primary Purpose: | Prevention |
Official Title: | Building Bridges: Addressing HIV Stigma in At-Risk Groups in Community Pharmacies |
Study Start Date : | July 2013 |
Estimated Primary Completion Date : | May 2016 |
Estimated Study Completion Date : | July 2016 |

Arm | Intervention/treatment |
---|---|
Active Comparator: HIV Test Offer
Group 1 (Control) is the current standard of care in HIV testing. A trained counselor provides required information to obtain informed consent for HIV testing and provides rapid HIV testing on site.
|
Behavioral: HIV Test Offer
HIV education and counseling from a trained Research Assistant and offering of a free rapid, oral HIV test
|
Experimental: General Health Screen Offer
In Group 2 (Intervention), a free general health screening is offered that may include a blood pressure check, blood glucose measurement, a Hepatitis C (HCV) test, and an HIV test.
|
Behavioral: General Health Screen Offer
A Research Assistant (RA) will provide health education on diabetes, hypertension, and HIV. The RA will then offer free blood pressure check, blood glucose measuring, rapid Hepatitis C (HCV) test, and a free, rapid oral HIV test.
|
- Acceptance of HIV Testing [ Time Frame: 30 minutes ]Rate of participation in voluntary rapid oral HIV test in each group
- Proportion of African immigrants that accept HIV testing [ Time Frame: 30 minutes ]Rate of HIV acceptance among the subgroup African immigrants, comparing between treatment and control groups
- Proportion of IDU that accept HIV testing [ Time Frame: 30 minutes ]Rate of HIV acceptance among the subgroup IDUs, comparing between treatment and control groups
- Proportion of minority MSM that accept HIV testing [ Time Frame: 30 minutes ]Rate of HIV acceptance among the subgroup minority MSM, comparing between treatment and control groups
- Linkage to Care [ Time Frame: up to one year ]Proportion of positively-screened participants that attend follow-up specialized medical care

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 64 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age 18 to 64 at time of recruitment
Exclusion Criteria:
- Known to be HIV positive
- Unable to understand the consent process for the study; or otherwise unable to consent to HIV testing

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01751100
United States, New York | |
Albert Einstein College of Medicine | |
Bronx, New York, United States, 10461 |
Principal Investigator: | Yvette Calderon, MD, MS | Albert Einstein College of Medicine, Inc. |
Responsible Party: | Yvette Calderon,MD, MS, Professor of Clinical Emergency Medicine, North Bronx Healthcare Network |
ClinicalTrials.gov Identifier: | NCT01751100 History of Changes |
Other Study ID Numbers: |
RFA-MH-13-092-001 |
First Posted: | December 17, 2012 Key Record Dates |
Last Update Posted: | May 8, 2015 |
Last Verified: | May 2015 |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |